[Skip to Content]
[Skip to Content Landing]
May 1983

Serum ?-Glutamyltransferase (GGT) and Thyroid Disease

Author Affiliations

Córdoba, Spain

Arch Intern Med. 1983;143(5):1070-1072. doi:10.1001/archinte.1983.00350050240050

To the Editor.  —We read with interest the article by Azizi entitled "γ-Glutamyl Transpeptidase Levels in Thyroid Disease" in the January Archives (1982;142:79-81). We have studied the serum GGT activity in 24 patients with untreated thyroid diseases—12 with hyperthyroidism (ten female and two male patients, aged 26 to 80 years; mean ± SEM, 58.16 ± 5.23 years) and 12 with hypothyroidism (eight female and four male patients, aged 12 to 70 years; mean ± SEM, 52.66 ± 4.81 years). A group of eight female and four male normal volunteers served as control subjects. Their mean ± SEM age was 35.91 ± 1.92 years. The diagnosis of thyroid disease was based on clinical findings and measurement of serum free thyroxine (T4) index and thyrotropin level. Serum GGT was assayed by a kinetic-spectrophotometric method according to Szasz.1 None of the patients or control subjects with conditions known to modifier serum

First Page Preview View Large
First page PDF preview
First page PDF preview